drugset / Trial / NCT06261203
Low Dose Aspirin for Prevention of Early Pregnancy Loss
RandomizedParallel-groupDouble-blindPrevention
Summary
Preeclampsia is a pregnancy-specific, multisystem disorder affecting 3% to 8% of pregnancies and remains a significant cause of maternal and neonatal morbidity and mortality worldwide. The World Health Organization estimates that approximately 76,000 maternal deaths annually are attributed to preeclampsia, accounting for 16% of global maternal mortality, with the majority occurring in low- and middle-income countries
Timeline
- Start
- 2023-07-01
- Primary completion
- 2025-07-01
- Completion
- 2025-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 81 mg | — |